LATEST TECHNOLOGY ADVANCES IN COSMACEUTICALS
Abstract
World consumers are looking for personal care products that supply multiple benefits with minimal efforts. They also expect the latest technology advances to be incorporated into innovative formulations. The trend toward therapeutic cosmetics will lead to a better understanding of modern ingredients and their assessment techniques. To obtain skin care formulations with real consumer-perceivable benefits and to optimize sensory attributes, formulators are resorting to technology that until recently was exclusively used in cosmetic products. Various formulations comes under special delivery systems like Vesicular, Particulate systems, emulsions type Particulate type and other delivery systems along with their applications are shown in this article, as it results in an economic uplift of cosmetic industry in various parts of the world. Little evidence is seen that nanoparticles in cosmetics and sunscreen might be a problem at this time and its need is further explored for a better understanding of these novel technologies. Thus, novel cosmaceutical delivery systems reviewed here possess enormous potential as next-generation smarter carrier systems.
Keywords:
Skin care formulations, novel cosmetic drug delivery systems, Vesicular Systems, Particulate systems, Latest cosmetic technologiesDOI
https://doi.org/10.25004/IJPSDR.2012.040302References
1. http://www.cosmetics.co.in
2. Singhal M, Khanna S, Nasa A. Cosmeceuticals for the Skin: An Overview. Asian J Pharm Clin Res. 2011; 4(2):1-6.
3. Sharma R. Cosmeceuticals and Herbal Drugs: Practical Uses. Int J Pharm Sci Res.2012; 3(1): 59-65.
4. Dureja H, Kaushik D, Gupta M, Kumar K, Lather V. Cosmeceuticals: An Emerging Concept. Indian J Pharmacol. 2005; 37(3):155-159.
5. Patravale VB, Mandawgade SD. Novel Cosmetic Delivery Systems: An Application Update. Int J Cosmetic Sci. 2008; 1:19-33.
6. Jonathan HZ, Adam F. Nanotechnology in Cosmetics and Sunscreens: An Update. J Drugs Dermatol. 2009; 8(10): 955-958.
7. Market Trends: The U.S. Cosmaceuticals and Anti-Aging Products Market, Packaged facts, Market Research Reports, 2005, 160 Pages, Pub ID: LA1037623.
8. Thomas M, Joshua C, Nick T, Jason K, David MB. The Citizen’s Guide to Nanotechnology: Cosmetics. North Carolina State University, 2008.
9. Mufti J, Cernasov D, Macchio R. New Technologies in Topical Delivery Systems. Happi. 2002; 39: 75-82.
10. Murthy RSR. Vesicular and Particulate drug delivery system. Nashik career Publication, 2010.
11. Lasic DD. Novel Applications of Liposomes. Trends Biotechnol. 1998; 16(7): 307-321.
12. Lautenschlager H, Barel AO, Paye M, Maibach HI. Liposomes, Handbook of Cosmetic Science and Technology, CRC Press Taylor & Francis Group, Boca Raton, 2006, pp. 155-163.
13. Cevc G. Transfersomes, Liposomes and Other Lipid Suspensions on the Skin: Permeation Enhancement, Vesicle Penetration, and Transdermal Drug Delivery. Crit Rev Ther Drug Career Syst. 1996; 13:257-388.
14. Thong HY, Zhai H, Maibach HI. Percutaneous Penetration Enhancers: An overview. Skin Pharmacol Physiol. 2007; 20: 272-282.
15. Ziboh VA, Miller CC, Cho Y. Metabolism of Polyunsaturated Fatty Acids by Skin Epidermal Enzymes: Generation of Anti-Inflammatory and Anti-Proliferative Metabolites. Am J Clin Nutr. 2000; 71: 361S-366S.
16. Moussaoui N, Cansell M, Denizot A. Marinosomes Marine Lipid-Based Liposomes: Physical Characterization and Potential Applications in Cosmetics. Int J Pharm.2002; 242:361-365.
17. Salavkar SM, Tamanekar RA, Athawale RB.Antioxidants in Skin Ageing-Future of Dermatology. Int J Green Pharm. 2011; 5(3):161-168.
18. http://www.protecingredia.com/products/barnet/ultrasomes.html
19. Suzuki K, Sakon K. The Applications of Liposomes to Cosmetics. Cosmet Toil.1990; 105:65-78.
20. Patravale VB, Mandawgade SD. Novel Cosmetic Delivery Systems: An Application Update. Int J Cosmetic Sci, 2008; 30:19-33.
21. Dayan N, Touitou E. Carriers for Skin Delivery of Trihexyphenidyl HCl: Ethosomes vs Liposomes. Biomaterials. 2000; 21:1879-85.
22. http://www.michaeltoddcosmetics.com/store/product/id/105/name/anti-wrinkle cream/category/moisturizer/category-id/52
23. http://www.michaeltoddcosmetics.com/store/product/category-id/52/category/moisturizer
24. http://www.encapsula.com/contract_manufacturing.html
25. http://www.sinere.com/nanominox-ms_en.html
26. Bombardelli E, Cristoni A, Morazzoni P. Phytosome in Functional Cosmetic. Fitoterapia 1995; 5: 387-401.
27. http://www.elsomresearch.com/shopping/products/antiaging.htm,
28. http://www.nutraingredients.com/Industry/Proprietary-CoQ10-formulation-demonstrates-superior-absorption
29. http://www.cosdocs.net/skincare_products.html
30. http://www.cosdocs.net/skincare_products.html
31. Saraf S, Jeswani G, Deep Kaur C, Saraf S. Development of Novel Herbal Cosmetic Cream with Curcuma Longa Extract Loaded Transfersomes for Antiwrinkle Effect. Afr J Pharm Pharacol. 2011; 5(8):1054-1062.
32. Van Hal D, Vanrensen A, Devringer T, Junginger H, Bouwstra J. Diffusion of Estradiol from Non-Ionic Surfactant Vesicles through Human Stratum-corneum in-vitro. STP Pharm Sci; 1996; 6:72-78.
33. Uchegbua IF, Vyas SP. Non-Ionic Surfactant Based Vesicles (Niosomes) in Drug Delivery. Int J Pharm.1998; 172: 33-70.
34. L’Oreal, US Patent 4830857, 1989.
35. L’Oréal, French Patent 2315991, 1975.
36. Ali N, Harikumar SL, Kaur A. Niosomes: An Excellent Tool for Drug Delivery. Int J Res Pharm Chem. 2012; 2(2):479-487.
37. Gupta A, Prajapati SK, Balamurugan M, Singh M, Bhatia D. Design and Development of A Proniosomal Transdermal Drug Delivery Systems for Captopril. Trop J Pharm Res. 2007; 6:687-693.
38. Nand K. Proniosome Gel: Potential Carrier System in Topical/Transdermal Delivery for Drugs and Cosmetics/Cosmeceuticals. Pharmainfo.net. 2010; 16:35.
39. Newton J, Stoller C. Silicone Technologies as Delivery Systems via Physical Association. Cosmet Toil. 2004; 69-78.
40. Newton J, Postiaux S, Stoller C. Silicone Elastomer Delivery Systems. Cosmet Toil.2004; 119:24-31.
41. Jershow P. Silicone Elastomers, Rapra Review Reports, 2002, ISBN 978-1 -85957-297-9.
42. Birman M, Lawrence N. Liposome Stability via Multi-Walled Delivery Systems. Cosmet Toil.2002; 117:51-58.
43. Gareth AH. Nanostructure-mediated drug delivery, Nanomed-Nanotechnol.2005; 1(1): 22-30.
44. Mathur R. US Patent6 251 425, 2001.
45. Weiner N. Influence of Non-Ionic Liposomal Composition on Topical Delivery of Peptide Drugs into Pilosebaceous Units. Cosmet Derm. 1997; 10:1186-1190.
46. http://www.sol-gel.com
47. Newton J, Postiaux S, Stoller C, Verhelst V. Silicone Technologies as Delivery Systems via Entrapment or Encapsulation. Dow Corning Europe, Seneffe, Belgium, Form No. 27-1178A-01, Printed in USA. AGP10181.
48. Lakshmi PK, Devi GS. Niosomal Methotrexate Gel in the Treatment of Localized Psoriasis: Phase I and Phase II Studies. Indian J Dermatol Venereol Leprol.2007; 73(3):157-161.
49. Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of Some Formulation Parameters on Flurbiprofen Encapsulation and Release Rates of Niosomes Prepared Form Proniosomes. Int J Pharm. 2008; 361:104-111.
50. Tsai YH, Fang JY, Yu SY, Wu PC, Huang YB. In-vitro Skin Preparation of Estradiol from Various Proniosomal Formulations. Int J Pharm 2001; 215: 91-99.
51. Mathur, R. US Patent 6 251425. Wilmington, DE, USA, 2001.
52. Majeti NV, Kumar R. Nano and Microparticles as Controlled Drug Delivery Devices. J Pharm Pharmaceutic Sci. 2000; 3(2): 234-358
53. Parison V. Active Delivery from Nylon Particles.Cosmet Toil.1993; 108:97-100.
54. Torrado S, Torrado JJ, Cadorniga R. Topical Application of Albumin Microspheres Containing Vitamin A: Drug Release and Availability.Int J Pharm.1992; 86:147-149.
55. Rogers K. Controlled Release Technology and Delivery Systems. Cosmet Toil. 1999; 114:53–60.
56. Meyer R. Delivery system handbook for personal care and cosmetic products: technology, Application and Formulations, Published in united states by William Andrew, ©2005, 2006, chapter 16, pp. 334
57. Nacht S, Katz M. The Microsponge: A Novel Topical Programmable Delivery System. Edited by David WO, Anfon H A. Volume 42, Marcel Dekker Inc, New York, 1992, pp. 299-325.
58. Embil K, Nacht S. The Microsponge Delivery System (MDS): A Topical Delivery System with Reduced Irritancy Incorporating Multiple Triggering Mechanisms for the Release of Actives. J Microencapsul. 1996; 13(5):575-88.
59. Khopade AJ, Jain S, Jain NK. The Microsponge. Eastern Pharmacist, March 1996; 49-53
60. Grimes PE. A Microsponge Formulation of Hydroquinone 4% and Retinol 0.15% in the Treatment of Melasma and Post Inflammatory Hyperpigmentation.Cutis. 2004; 74(6):362-8.
61. KoralEmbi VP. UK Patent Application No: 0101058.6, 15 Jan 2000.
62. Asensio JA, Grisoni P, Gomez Y, Martinez S, Salvatore Gargano S, Andreas A. Eco-Friendly Cosmetic Delivery Systems Based on Natural Biopolymers,Skin Care Forum BASF Personal Care and Nutrition GmbH,©2000 – 2011, issue 44.
63. Guterres SS, Alves MP, Pohlmann AR, Polymeric Nanoparticles, Nanospheres and Nanocapsules, for Cutaneous Applications,Drug Target Insights. 2007; 2: 147-157.
64. Blank C. Nanospheres in Skin Care, Jun 14, 2011. OR http://www.livestrong.com/article/280381-nanospheres-in-skin-care/#ixzz1osVVPsX8
65. Müller RH, Radtke M, Wissing SA. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) in Cosmetic and Dermatological Preparations. Adv Drug Deliv Rev Suppl. 2002; 54: S131-S15.
66. Müller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured Lipid Carriers (NLC) in Cosmetic Dermal Products. Adv Drug Deliv Rev. 2007; 59:522-30.
67. Hassan Hany M, El Gazayerly ON. Rice Bran Solid Lipid Nanoparticles: Preparation and Characterization. Int. J. Res. Drug Deliv.2011; 1(2): 6-9.
68. Müller RH, Dingler A. The Next Generation after the Liposomes: Solid Lipid Nanoparticles (SLN, Lipopearls) as Dermal Carrier in Cosmetics. Eurocosmetics .1998; 7: 18-26.
69. Dingler A, Blum RP, Niehus H, Müller RH, Gohla S. Solid Lipid Nanoparticles (SLN/Lipopearls)-A Pharmaceutical and Cosmetic Carrier for the Application of Vitamin E In Dermal Products. J Microencapsul.1999; 16:751-767.
70. Luppi B, Cerchiara T, Bigucci F, Basile R, Zecchi V. Polymeric Nanoparticles Composed of Fatty Acids and Polyvinylalcohol for Topical Application of Sunscreens. J Pharm Pharacol.2004; 56:407-411.
71. Alvarez RR, Barre G, Guy RH, Fessi H. Biodegradable Polymer Nanocapsules Containing a Sunscreen Agent: Preparation and Photoprotection. Eur J Pharm Biopharm. 2001 Sep; 52(2):191-5.
72. Wissing SA, Müller RH. A Novel Sunscreen System Based on Tocopherol Acetate Incorporated into Solid Lipid Nanoparticles (SLN). Int J Cosm Sci. 2001; 23:233-243.
73. Bhalekar MR, Pokharkar V, Madgulkar A, Patil N. Preparation and Evaluation of Miconazole Nitrate-Loaded Solid Lipid Nanoparticles for Topical Delivery. AAPS PharmSciTech. 2009; 10(1):289-96.
74. Pardeike J, Hommoss A, Muller RH. Lipid Nanoparticles (SLN, NLC) in Cosmetic and Pharmaceutical Dermal Products. Int J Pharm.2009; 366:170-184.
75. Song C, Liu S. A New Healthy Sunscreen System For Human: Solid Lipid Nanoparticles as Carrier for 3, 4, 5-Trimethoxybenzoylchitin and the Improvement by Adding Vitamin E. Int J Biol Macromol. 2005; 36:116-119.
76. Mei Z, Wu Q, Hu S, Li X, Yang X. Triptolide Loaded Solid Lipid Nanoparticle Hydrogel for Topical Application, Drug Del Ind Pharm. 2005 Jan; 31(2):161-8.
77. Talegaonkar S, Azeem A, Farhan J, Ahmad, Khar RK, Pathan SA, Khan ZI. Microemulsions: A Novel Approach to Enhanced Drug Delivery. Recent Pat Drug Deliv Formul.2008; 2: 238-257.
78. Bevacqua AJ, Konstantinos ML, Lahanas M.Liquid Crystals in Multiple Emulsion. Cosmet Toil.1991; 106:53-56.
79. Silva E, Wang Y, Zhu Y. Short Liquid Crystal Polymer Survey. Academia edu.2012.
80. http://ncsu.academia.edu/EdmirSilva/Papers/423637/A_SHORT_LIQUID_CRYSTAL_POLYMER_SURVEY
81. Liebowitz M, Brandli EH. US Patent 4 013 475. Colgate-Palmolive Company, New York, 1977.
82. Sonneville AO, Simonnet JT, Alloret FL. Nanoemulsions: A New Vehicle for Skin Care Products. Adv. Colloid Interface Sci.2004; 108–109, 145–149.
83. Fox C. Cosmetic and Pharmaceutical Vehicles: Skin Care, Hair Care, Makeup and Sunscreens. Cosmet.Toil.1998; 113:45-56.
84. http://www.mc2biotek.dk/drug-delivery-solutions/applications/dermatology/
85. Barnett JM, Scher RK. Nail cosmetics. Int J Dermatol.1992; 31:675.
86. Gers-Barlag H, Muller A, Beiersdorf AG.US Patent Application 20030175221. Hamburg, 2003.
87. Gers-Barlag H, Muller A, Beiersdorf AG. US Patent 6 410 035, Hamburg, 2002.
88. Gers-Barlag H, Muller A, Beiersdorf AG. US Patent 6 703 032, Hamburg, 2004.
89. Iwai H, Fukasava J, Suzuki T. A Liquid Crystal Application in Skin Care Cosmetics. Int J Cosmet Sci. 1998; 20(2): 87-102.
90. Brinon L, Geiger S, Alard V, Doucet J, Tranchant JF, Couarraze G. Percutaneous Absorption of Sunscreens from Liquid Crystalline Phases. J Control release.1999; 60: 67-76.
91. Cioca G, James AH, Manuel LT, Herstein M, Walter P.US4999348, 1991.
92. Mitsuno Y, Nomaguchi K, Suzuki T. US4767625, 1988.
93. Fairhurst D, Mitchnick MA. Sub-micron encapsulation of organic sunscreens. Cosmet Toilet.1995; 110(9): 47–50.
94. http://www.pietrulla-kosmetika.com/index.php?lng=en&page=viewcategory&cat=8
95. Yamazaki H. Novel O/W Type Nail Enamel. Fragrance J. 1992; 20:86–88.
96. Valenty VB, Scottsdale AZ. US Patent 5 456 905. Ultraset Limited Partnership, 1995.
97. Frelichowska J, Bolzinger MA. Topical Delivery of Lipophilic Drugs from O/W Pickering Emulsions. Int J Pharm. 2009; 371(1-2): 56-63.
98. Naveed A, Yasemin Y. Formulation and Evaluation of a Cosmetic Multiple Emulsion. Pak. J. Pharm. Sci. 2008; 21(1):45-50.
99. Dias M, Guffogg P, Wheeler D, Jordan MW. Us Patent, 20060239947A1, 2010.
100. Mokhtar M, Sammour OA, Hammad MA, Megrab NA.Effect of Some Formulation Parameters on Flurbiprofen Encapsulation and Release Rates of Niosomes Prepared form Proniosomes. Int J Pharm. 2008; 361: 104-111.
101. Duchene D, Wouessidjewe D, Poelman MC. Cyclodextrins in Cosmetics: Novel Cosmetic Delivery Systems. Marcel Dekker Inc., New York, 1999, pp. 275-278
102. Amann M, Dressnandt G. Solving Problems with Cyclodextrins in Cosmetics. Cosmet Toil. 1993; 108: 90-95.
103. Citernesi U, Sciacchitano M. Cyclodextrins in functional dermocosmetics. Cosmet Toil.1995; 110:53-61.
104. Boyd BJ. Characterisation of Drug Release from Cubosomes Using the Pressure Ultrafiltration Method. Int J Pharm. 2003; 260:239-47.
105. Spicer P. Progress in Liquid Crystalline Dispersions: Cubosomes. Curr Opin Colloid Int Sci. 2005; 10:274-279.
106. Afriat I, Biatry B. Use of Cubic Gel Particles as Agents against Pollutants, Especially in a Cosmetic Composition. Eur Pat Appl. 2001.
107. Schreiber J, Albrecht H. Hair Care Products With A Content of Disperse Phase Liquid Crystals Which Form Cubic Phases. Ger Offen. 2002.
108. Svenson S, Tomalia DA. Dendrimers in Biomedical Applications - Reflections on the Field. Adv Drug Deliv Rev. 2005; 57:2106-2129.
109. L’Oreal, US Patent 6432423, 2002.
110. L’Oreal, US Patent 6399048, 2002.
111. L’Oreal, US Patent 6287552, 2001
112. Franzke M, Steinbrecht K, Clausen T, Baecker S, Titze J. US Patent 6068835, 2000.
113. Huczko A, Lange H. Fullerenes: Experimental Evidence for a Null Risk of Skin Irritation and Allergy. Fullerene Sci Technol. 1999; 7:935-9.
114. Fumelli C, Marconi A, Salvioli S. Carboxyfullerenes Protect Human Keratinocytes from Ultraviolet-B-Induced Apoptosis. J Invest Dermato. 2000; 115(5):835-41.
115. Bilensoy E, Cyclodextrin in Pharmaceutics, Cosmetics, and Biomedicine, Current and Future Industrial Applications, Wiley, chapter 4, section 4.1.1.
116. Gopal G, Shailendra S, Swarnlata S. Cubosomes: An Overview. Biol Pharm Bull. 2007; 309(2):350-353.
117. Gaurav TT, Hannah HC. The Role of Dendrimers in Topical Drug Delivery. Pharm Tech 2008; 32(11): 88-98.
118. Petersen R. Abbott GmbH & Co., US Patent 60/866233, 2008.
119. Numanoglu U, Sen T, Tarimci N, Kartal M, Koo OM, Onyuksel H. Use of Cyclodextrins as a Cosmetic Delivery System for Fragrance Materials: Linalool and Benzyl Acetate. AAPS PharmSciTech. 2007, 8(4):E85.
120. Schmidt JB, Binder M, Macheines UV, Bieglmager C.New Treatment of Atrophic Acne Scars by Iontophoresis with Estriol and Tretinoin. Int J Dermatol.1995; 34:57-62.
121. Shigene S, Murakami T, Yata N, Ikuta Y. Treatment of Keloid and Hypertrophic Scars by Iontophoretic Transdermal Delivery of Tranilast. Scand J Plast Reconstr Surg Hand Surg. 1997; 31:151-154.
122. Zhao L, Hung L, Choy T. Delivery of Medication by Iontophoresis to Treat Post-Burn Hypertrophic Scars: Investigation of a New Electronic Technique. Burns. 1997; 23:S27.
123. Fotinos SA, Barel AO, Paye M, Maibach HI. Cosmetic Patches. In: Handbook of Cosmetic Science and Technology, Marcel Dekker Inc., New York 2001. pp. 233-243.
124. Tamarkin D. Enhancing Cosmetic Efficacy by Orders of Magnitude Using Thin and Flexible Microelectronic Patches. Health Beauty America.2003; 1:9-10.
125. http://www.collagenelife.com/iontophoresis.html
126. Tamarkin D. Using Iontophoresis to Enhance Cosmetic Delivery. Cosmet Toil. 2004; 119:63-74.
127. Schmidt JB, Donath P, Hannes J. Tretinoin-Iontophoresis in Atrophic Acne Scars. Int J Dermatol. 1999; 38:149-153.
128. http://www.collagenelife.com/iontophoresis.html
129. De Paepe K, Wibaux A, Ward C, Rogiers V. Skin Efficacy and Biophysical Assessment of Glycerol-Containing Hydrocolloid. Skin Pharmacol Physiol. 2009; 22:258-265.
130. Mahdavi H, Kermani Z, Faghihi G. Preparation and Evaluation of Cosmetic Patches Containing Lactic and Glycolic Acids, Indian J Dermatol Venereol Leprol. 2006; 72(6):432-436.
131. Oberdorster E. Manufactured Nanomaterials (Fullerenes, C60) Induce Oxidative Stress in the Brain of Juvenile Large Mouth Bass .Environ Health Perspect.2004; 112:1058-1062.
132. Sayes C, Fortner J, Guo W, Lyon D, Boyd A, Ausman K, Tao Y, Sitharaman B, Wilson L, Hughes J, West J, Colvin V. The Differential Cytotoxicity of Water-Soluble Fullerenes. 2004; 4:1881-1887.
133. Nel A, Xia T, Li N. Toxic Potential of Materials at the Nanolevel. Scienc. 2006; 311:622-62
134. Oberdörster G, Oberdörster E, Oberdorster J. Nanotoxicology: An Emerging Discipline from Studies of Ultrafine Particles. Environmental Health Perspectives. 2005; 113(7):823-839
135. Mavon A, Miquel C, Lejeune O, Payre B, Moretto P. In-vitro Percutaneous Absorption and in-vivo Stratum Corneum Distribution of an Organic and A Mineral Sunscreen. Skin Pharmacol Physiol. 2007; 20:10-20.
136. The Royal Society and the Royal Academy of Engineering, UK. 2004. Nanoscience and nanotechnologies. Section 8.3.3, paragraphs 24, 23, and 25.
137. Calster GV, Bowman DM. Regulatory Design for New Technologies: Spaghetti Junction or Bauhaus Principles for Regulating Innovative Cosmetic Products. 2009; XXV, 94:75-93
138. Stafford N. New nano rule for EU cosmetics, Advancing the Chemical Sciences, 2009, Royal society of Chemistry, Hamburg, Germany.
139. Burke K. Nanotech widespread in cosmetics, report finds, The Sydney Morning Herald, Nov. 24, 2009.
140. European Commission, Health and Consumer Protection Directorate-General, Scientific Committee on consumer Product, The SCCP notes of guidance for the testing of Cosmetic ingredients and their safety evaluation , 6th Revision, Adopted by the SCCP during the 10th plenary meeting of 19 December 2006.
141. U.S. Environmental Protection Agency Office Of Inspector General, EPA Needs to Manage Nanomaterial Risks More Effectively, Report No. 12-P-0162, December 29, 2011.
142. Perspectives on FDA's Regulation of Nanotechnology: Emerging Challenges and Potential Solutions, Institute of Food technologist, 2009; 8(4).
2. Singhal M, Khanna S, Nasa A. Cosmeceuticals for the Skin: An Overview. Asian J Pharm Clin Res. 2011; 4(2):1-6.
3. Sharma R. Cosmeceuticals and Herbal Drugs: Practical Uses. Int J Pharm Sci Res.2012; 3(1): 59-65.
4. Dureja H, Kaushik D, Gupta M, Kumar K, Lather V. Cosmeceuticals: An Emerging Concept. Indian J Pharmacol. 2005; 37(3):155-159.
5. Patravale VB, Mandawgade SD. Novel Cosmetic Delivery Systems: An Application Update. Int J Cosmetic Sci. 2008; 1:19-33.
6. Jonathan HZ, Adam F. Nanotechnology in Cosmetics and Sunscreens: An Update. J Drugs Dermatol. 2009; 8(10): 955-958.
7. Market Trends: The U.S. Cosmaceuticals and Anti-Aging Products Market, Packaged facts, Market Research Reports, 2005, 160 Pages, Pub ID: LA1037623.
8. Thomas M, Joshua C, Nick T, Jason K, David MB. The Citizen’s Guide to Nanotechnology: Cosmetics. North Carolina State University, 2008.
9. Mufti J, Cernasov D, Macchio R. New Technologies in Topical Delivery Systems. Happi. 2002; 39: 75-82.
10. Murthy RSR. Vesicular and Particulate drug delivery system. Nashik career Publication, 2010.
11. Lasic DD. Novel Applications of Liposomes. Trends Biotechnol. 1998; 16(7): 307-321.
12. Lautenschlager H, Barel AO, Paye M, Maibach HI. Liposomes, Handbook of Cosmetic Science and Technology, CRC Press Taylor & Francis Group, Boca Raton, 2006, pp. 155-163.
13. Cevc G. Transfersomes, Liposomes and Other Lipid Suspensions on the Skin: Permeation Enhancement, Vesicle Penetration, and Transdermal Drug Delivery. Crit Rev Ther Drug Career Syst. 1996; 13:257-388.
14. Thong HY, Zhai H, Maibach HI. Percutaneous Penetration Enhancers: An overview. Skin Pharmacol Physiol. 2007; 20: 272-282.
15. Ziboh VA, Miller CC, Cho Y. Metabolism of Polyunsaturated Fatty Acids by Skin Epidermal Enzymes: Generation of Anti-Inflammatory and Anti-Proliferative Metabolites. Am J Clin Nutr. 2000; 71: 361S-366S.
16. Moussaoui N, Cansell M, Denizot A. Marinosomes Marine Lipid-Based Liposomes: Physical Characterization and Potential Applications in Cosmetics. Int J Pharm.2002; 242:361-365.
17. Salavkar SM, Tamanekar RA, Athawale RB.Antioxidants in Skin Ageing-Future of Dermatology. Int J Green Pharm. 2011; 5(3):161-168.
18. http://www.protecingredia.com/products/barnet/ultrasomes.html
19. Suzuki K, Sakon K. The Applications of Liposomes to Cosmetics. Cosmet Toil.1990; 105:65-78.
20. Patravale VB, Mandawgade SD. Novel Cosmetic Delivery Systems: An Application Update. Int J Cosmetic Sci, 2008; 30:19-33.
21. Dayan N, Touitou E. Carriers for Skin Delivery of Trihexyphenidyl HCl: Ethosomes vs Liposomes. Biomaterials. 2000; 21:1879-85.
22. http://www.michaeltoddcosmetics.com/store/product/id/105/name/anti-wrinkle cream/category/moisturizer/category-id/52
23. http://www.michaeltoddcosmetics.com/store/product/category-id/52/category/moisturizer
24. http://www.encapsula.com/contract_manufacturing.html
25. http://www.sinere.com/nanominox-ms_en.html
26. Bombardelli E, Cristoni A, Morazzoni P. Phytosome in Functional Cosmetic. Fitoterapia 1995; 5: 387-401.
27. http://www.elsomresearch.com/shopping/products/antiaging.htm,
28. http://www.nutraingredients.com/Industry/Proprietary-CoQ10-formulation-demonstrates-superior-absorption
29. http://www.cosdocs.net/skincare_products.html
30. http://www.cosdocs.net/skincare_products.html
31. Saraf S, Jeswani G, Deep Kaur C, Saraf S. Development of Novel Herbal Cosmetic Cream with Curcuma Longa Extract Loaded Transfersomes for Antiwrinkle Effect. Afr J Pharm Pharacol. 2011; 5(8):1054-1062.
32. Van Hal D, Vanrensen A, Devringer T, Junginger H, Bouwstra J. Diffusion of Estradiol from Non-Ionic Surfactant Vesicles through Human Stratum-corneum in-vitro. STP Pharm Sci; 1996; 6:72-78.
33. Uchegbua IF, Vyas SP. Non-Ionic Surfactant Based Vesicles (Niosomes) in Drug Delivery. Int J Pharm.1998; 172: 33-70.
34. L’Oreal, US Patent 4830857, 1989.
35. L’Oréal, French Patent 2315991, 1975.
36. Ali N, Harikumar SL, Kaur A. Niosomes: An Excellent Tool for Drug Delivery. Int J Res Pharm Chem. 2012; 2(2):479-487.
37. Gupta A, Prajapati SK, Balamurugan M, Singh M, Bhatia D. Design and Development of A Proniosomal Transdermal Drug Delivery Systems for Captopril. Trop J Pharm Res. 2007; 6:687-693.
38. Nand K. Proniosome Gel: Potential Carrier System in Topical/Transdermal Delivery for Drugs and Cosmetics/Cosmeceuticals. Pharmainfo.net. 2010; 16:35.
39. Newton J, Stoller C. Silicone Technologies as Delivery Systems via Physical Association. Cosmet Toil. 2004; 69-78.
40. Newton J, Postiaux S, Stoller C. Silicone Elastomer Delivery Systems. Cosmet Toil.2004; 119:24-31.
41. Jershow P. Silicone Elastomers, Rapra Review Reports, 2002, ISBN 978-1 -85957-297-9.
42. Birman M, Lawrence N. Liposome Stability via Multi-Walled Delivery Systems. Cosmet Toil.2002; 117:51-58.
43. Gareth AH. Nanostructure-mediated drug delivery, Nanomed-Nanotechnol.2005; 1(1): 22-30.
44. Mathur R. US Patent6 251 425, 2001.
45. Weiner N. Influence of Non-Ionic Liposomal Composition on Topical Delivery of Peptide Drugs into Pilosebaceous Units. Cosmet Derm. 1997; 10:1186-1190.
46. http://www.sol-gel.com
47. Newton J, Postiaux S, Stoller C, Verhelst V. Silicone Technologies as Delivery Systems via Entrapment or Encapsulation. Dow Corning Europe, Seneffe, Belgium, Form No. 27-1178A-01, Printed in USA. AGP10181.
48. Lakshmi PK, Devi GS. Niosomal Methotrexate Gel in the Treatment of Localized Psoriasis: Phase I and Phase II Studies. Indian J Dermatol Venereol Leprol.2007; 73(3):157-161.
49. Mokhtar M, Sammour OA, Hammad MA, Megrab NA. Effect of Some Formulation Parameters on Flurbiprofen Encapsulation and Release Rates of Niosomes Prepared Form Proniosomes. Int J Pharm. 2008; 361:104-111.
50. Tsai YH, Fang JY, Yu SY, Wu PC, Huang YB. In-vitro Skin Preparation of Estradiol from Various Proniosomal Formulations. Int J Pharm 2001; 215: 91-99.
51. Mathur, R. US Patent 6 251425. Wilmington, DE, USA, 2001.
52. Majeti NV, Kumar R. Nano and Microparticles as Controlled Drug Delivery Devices. J Pharm Pharmaceutic Sci. 2000; 3(2): 234-358
53. Parison V. Active Delivery from Nylon Particles.Cosmet Toil.1993; 108:97-100.
54. Torrado S, Torrado JJ, Cadorniga R. Topical Application of Albumin Microspheres Containing Vitamin A: Drug Release and Availability.Int J Pharm.1992; 86:147-149.
55. Rogers K. Controlled Release Technology and Delivery Systems. Cosmet Toil. 1999; 114:53–60.
56. Meyer R. Delivery system handbook for personal care and cosmetic products: technology, Application and Formulations, Published in united states by William Andrew, ©2005, 2006, chapter 16, pp. 334
57. Nacht S, Katz M. The Microsponge: A Novel Topical Programmable Delivery System. Edited by David WO, Anfon H A. Volume 42, Marcel Dekker Inc, New York, 1992, pp. 299-325.
58. Embil K, Nacht S. The Microsponge Delivery System (MDS): A Topical Delivery System with Reduced Irritancy Incorporating Multiple Triggering Mechanisms for the Release of Actives. J Microencapsul. 1996; 13(5):575-88.
59. Khopade AJ, Jain S, Jain NK. The Microsponge. Eastern Pharmacist, March 1996; 49-53
60. Grimes PE. A Microsponge Formulation of Hydroquinone 4% and Retinol 0.15% in the Treatment of Melasma and Post Inflammatory Hyperpigmentation.Cutis. 2004; 74(6):362-8.
61. KoralEmbi VP. UK Patent Application No: 0101058.6, 15 Jan 2000.
62. Asensio JA, Grisoni P, Gomez Y, Martinez S, Salvatore Gargano S, Andreas A. Eco-Friendly Cosmetic Delivery Systems Based on Natural Biopolymers,Skin Care Forum BASF Personal Care and Nutrition GmbH,©2000 – 2011, issue 44.
63. Guterres SS, Alves MP, Pohlmann AR, Polymeric Nanoparticles, Nanospheres and Nanocapsules, for Cutaneous Applications,Drug Target Insights. 2007; 2: 147-157.
64. Blank C. Nanospheres in Skin Care, Jun 14, 2011. OR http://www.livestrong.com/article/280381-nanospheres-in-skin-care/#ixzz1osVVPsX8
65. Müller RH, Radtke M, Wissing SA. Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) in Cosmetic and Dermatological Preparations. Adv Drug Deliv Rev Suppl. 2002; 54: S131-S15.
66. Müller RH, Petersen RD, Hommoss A, Pardeike J. Nanostructured Lipid Carriers (NLC) in Cosmetic Dermal Products. Adv Drug Deliv Rev. 2007; 59:522-30.
67. Hassan Hany M, El Gazayerly ON. Rice Bran Solid Lipid Nanoparticles: Preparation and Characterization. Int. J. Res. Drug Deliv.2011; 1(2): 6-9.
68. Müller RH, Dingler A. The Next Generation after the Liposomes: Solid Lipid Nanoparticles (SLN, Lipopearls) as Dermal Carrier in Cosmetics. Eurocosmetics .1998; 7: 18-26.
69. Dingler A, Blum RP, Niehus H, Müller RH, Gohla S. Solid Lipid Nanoparticles (SLN/Lipopearls)-A Pharmaceutical and Cosmetic Carrier for the Application of Vitamin E In Dermal Products. J Microencapsul.1999; 16:751-767.
70. Luppi B, Cerchiara T, Bigucci F, Basile R, Zecchi V. Polymeric Nanoparticles Composed of Fatty Acids and Polyvinylalcohol for Topical Application of Sunscreens. J Pharm Pharacol.2004; 56:407-411.
71. Alvarez RR, Barre G, Guy RH, Fessi H. Biodegradable Polymer Nanocapsules Containing a Sunscreen Agent: Preparation and Photoprotection. Eur J Pharm Biopharm. 2001 Sep; 52(2):191-5.
72. Wissing SA, Müller RH. A Novel Sunscreen System Based on Tocopherol Acetate Incorporated into Solid Lipid Nanoparticles (SLN). Int J Cosm Sci. 2001; 23:233-243.
73. Bhalekar MR, Pokharkar V, Madgulkar A, Patil N. Preparation and Evaluation of Miconazole Nitrate-Loaded Solid Lipid Nanoparticles for Topical Delivery. AAPS PharmSciTech. 2009; 10(1):289-96.
74. Pardeike J, Hommoss A, Muller RH. Lipid Nanoparticles (SLN, NLC) in Cosmetic and Pharmaceutical Dermal Products. Int J Pharm.2009; 366:170-184.
75. Song C, Liu S. A New Healthy Sunscreen System For Human: Solid Lipid Nanoparticles as Carrier for 3, 4, 5-Trimethoxybenzoylchitin and the Improvement by Adding Vitamin E. Int J Biol Macromol. 2005; 36:116-119.
76. Mei Z, Wu Q, Hu S, Li X, Yang X. Triptolide Loaded Solid Lipid Nanoparticle Hydrogel for Topical Application, Drug Del Ind Pharm. 2005 Jan; 31(2):161-8.
77. Talegaonkar S, Azeem A, Farhan J, Ahmad, Khar RK, Pathan SA, Khan ZI. Microemulsions: A Novel Approach to Enhanced Drug Delivery. Recent Pat Drug Deliv Formul.2008; 2: 238-257.
78. Bevacqua AJ, Konstantinos ML, Lahanas M.Liquid Crystals in Multiple Emulsion. Cosmet Toil.1991; 106:53-56.
79. Silva E, Wang Y, Zhu Y. Short Liquid Crystal Polymer Survey. Academia edu.2012.
80. http://ncsu.academia.edu/EdmirSilva/Papers/423637/A_SHORT_LIQUID_CRYSTAL_POLYMER_SURVEY
81. Liebowitz M, Brandli EH. US Patent 4 013 475. Colgate-Palmolive Company, New York, 1977.
82. Sonneville AO, Simonnet JT, Alloret FL. Nanoemulsions: A New Vehicle for Skin Care Products. Adv. Colloid Interface Sci.2004; 108–109, 145–149.
83. Fox C. Cosmetic and Pharmaceutical Vehicles: Skin Care, Hair Care, Makeup and Sunscreens. Cosmet.Toil.1998; 113:45-56.
84. http://www.mc2biotek.dk/drug-delivery-solutions/applications/dermatology/
85. Barnett JM, Scher RK. Nail cosmetics. Int J Dermatol.1992; 31:675.
86. Gers-Barlag H, Muller A, Beiersdorf AG.US Patent Application 20030175221. Hamburg, 2003.
87. Gers-Barlag H, Muller A, Beiersdorf AG. US Patent 6 410 035, Hamburg, 2002.
88. Gers-Barlag H, Muller A, Beiersdorf AG. US Patent 6 703 032, Hamburg, 2004.
89. Iwai H, Fukasava J, Suzuki T. A Liquid Crystal Application in Skin Care Cosmetics. Int J Cosmet Sci. 1998; 20(2): 87-102.
90. Brinon L, Geiger S, Alard V, Doucet J, Tranchant JF, Couarraze G. Percutaneous Absorption of Sunscreens from Liquid Crystalline Phases. J Control release.1999; 60: 67-76.
91. Cioca G, James AH, Manuel LT, Herstein M, Walter P.US4999348, 1991.
92. Mitsuno Y, Nomaguchi K, Suzuki T. US4767625, 1988.
93. Fairhurst D, Mitchnick MA. Sub-micron encapsulation of organic sunscreens. Cosmet Toilet.1995; 110(9): 47–50.
94. http://www.pietrulla-kosmetika.com/index.php?lng=en&page=viewcategory&cat=8
95. Yamazaki H. Novel O/W Type Nail Enamel. Fragrance J. 1992; 20:86–88.
96. Valenty VB, Scottsdale AZ. US Patent 5 456 905. Ultraset Limited Partnership, 1995.
97. Frelichowska J, Bolzinger MA. Topical Delivery of Lipophilic Drugs from O/W Pickering Emulsions. Int J Pharm. 2009; 371(1-2): 56-63.
98. Naveed A, Yasemin Y. Formulation and Evaluation of a Cosmetic Multiple Emulsion. Pak. J. Pharm. Sci. 2008; 21(1):45-50.
99. Dias M, Guffogg P, Wheeler D, Jordan MW. Us Patent, 20060239947A1, 2010.
100. Mokhtar M, Sammour OA, Hammad MA, Megrab NA.Effect of Some Formulation Parameters on Flurbiprofen Encapsulation and Release Rates of Niosomes Prepared form Proniosomes. Int J Pharm. 2008; 361: 104-111.
101. Duchene D, Wouessidjewe D, Poelman MC. Cyclodextrins in Cosmetics: Novel Cosmetic Delivery Systems. Marcel Dekker Inc., New York, 1999, pp. 275-278
102. Amann M, Dressnandt G. Solving Problems with Cyclodextrins in Cosmetics. Cosmet Toil. 1993; 108: 90-95.
103. Citernesi U, Sciacchitano M. Cyclodextrins in functional dermocosmetics. Cosmet Toil.1995; 110:53-61.
104. Boyd BJ. Characterisation of Drug Release from Cubosomes Using the Pressure Ultrafiltration Method. Int J Pharm. 2003; 260:239-47.
105. Spicer P. Progress in Liquid Crystalline Dispersions: Cubosomes. Curr Opin Colloid Int Sci. 2005; 10:274-279.
106. Afriat I, Biatry B. Use of Cubic Gel Particles as Agents against Pollutants, Especially in a Cosmetic Composition. Eur Pat Appl. 2001.
107. Schreiber J, Albrecht H. Hair Care Products With A Content of Disperse Phase Liquid Crystals Which Form Cubic Phases. Ger Offen. 2002.
108. Svenson S, Tomalia DA. Dendrimers in Biomedical Applications - Reflections on the Field. Adv Drug Deliv Rev. 2005; 57:2106-2129.
109. L’Oreal, US Patent 6432423, 2002.
110. L’Oreal, US Patent 6399048, 2002.
111. L’Oreal, US Patent 6287552, 2001
112. Franzke M, Steinbrecht K, Clausen T, Baecker S, Titze J. US Patent 6068835, 2000.
113. Huczko A, Lange H. Fullerenes: Experimental Evidence for a Null Risk of Skin Irritation and Allergy. Fullerene Sci Technol. 1999; 7:935-9.
114. Fumelli C, Marconi A, Salvioli S. Carboxyfullerenes Protect Human Keratinocytes from Ultraviolet-B-Induced Apoptosis. J Invest Dermato. 2000; 115(5):835-41.
115. Bilensoy E, Cyclodextrin in Pharmaceutics, Cosmetics, and Biomedicine, Current and Future Industrial Applications, Wiley, chapter 4, section 4.1.1.
116. Gopal G, Shailendra S, Swarnlata S. Cubosomes: An Overview. Biol Pharm Bull. 2007; 309(2):350-353.
117. Gaurav TT, Hannah HC. The Role of Dendrimers in Topical Drug Delivery. Pharm Tech 2008; 32(11): 88-98.
118. Petersen R. Abbott GmbH & Co., US Patent 60/866233, 2008.
119. Numanoglu U, Sen T, Tarimci N, Kartal M, Koo OM, Onyuksel H. Use of Cyclodextrins as a Cosmetic Delivery System for Fragrance Materials: Linalool and Benzyl Acetate. AAPS PharmSciTech. 2007, 8(4):E85.
120. Schmidt JB, Binder M, Macheines UV, Bieglmager C.New Treatment of Atrophic Acne Scars by Iontophoresis with Estriol and Tretinoin. Int J Dermatol.1995; 34:57-62.
121. Shigene S, Murakami T, Yata N, Ikuta Y. Treatment of Keloid and Hypertrophic Scars by Iontophoretic Transdermal Delivery of Tranilast. Scand J Plast Reconstr Surg Hand Surg. 1997; 31:151-154.
122. Zhao L, Hung L, Choy T. Delivery of Medication by Iontophoresis to Treat Post-Burn Hypertrophic Scars: Investigation of a New Electronic Technique. Burns. 1997; 23:S27.
123. Fotinos SA, Barel AO, Paye M, Maibach HI. Cosmetic Patches. In: Handbook of Cosmetic Science and Technology, Marcel Dekker Inc., New York 2001. pp. 233-243.
124. Tamarkin D. Enhancing Cosmetic Efficacy by Orders of Magnitude Using Thin and Flexible Microelectronic Patches. Health Beauty America.2003; 1:9-10.
125. http://www.collagenelife.com/iontophoresis.html
126. Tamarkin D. Using Iontophoresis to Enhance Cosmetic Delivery. Cosmet Toil. 2004; 119:63-74.
127. Schmidt JB, Donath P, Hannes J. Tretinoin-Iontophoresis in Atrophic Acne Scars. Int J Dermatol. 1999; 38:149-153.
128. http://www.collagenelife.com/iontophoresis.html
129. De Paepe K, Wibaux A, Ward C, Rogiers V. Skin Efficacy and Biophysical Assessment of Glycerol-Containing Hydrocolloid. Skin Pharmacol Physiol. 2009; 22:258-265.
130. Mahdavi H, Kermani Z, Faghihi G. Preparation and Evaluation of Cosmetic Patches Containing Lactic and Glycolic Acids, Indian J Dermatol Venereol Leprol. 2006; 72(6):432-436.
131. Oberdorster E. Manufactured Nanomaterials (Fullerenes, C60) Induce Oxidative Stress in the Brain of Juvenile Large Mouth Bass .Environ Health Perspect.2004; 112:1058-1062.
132. Sayes C, Fortner J, Guo W, Lyon D, Boyd A, Ausman K, Tao Y, Sitharaman B, Wilson L, Hughes J, West J, Colvin V. The Differential Cytotoxicity of Water-Soluble Fullerenes. 2004; 4:1881-1887.
133. Nel A, Xia T, Li N. Toxic Potential of Materials at the Nanolevel. Scienc. 2006; 311:622-62
134. Oberdörster G, Oberdörster E, Oberdorster J. Nanotoxicology: An Emerging Discipline from Studies of Ultrafine Particles. Environmental Health Perspectives. 2005; 113(7):823-839
135. Mavon A, Miquel C, Lejeune O, Payre B, Moretto P. In-vitro Percutaneous Absorption and in-vivo Stratum Corneum Distribution of an Organic and A Mineral Sunscreen. Skin Pharmacol Physiol. 2007; 20:10-20.
136. The Royal Society and the Royal Academy of Engineering, UK. 2004. Nanoscience and nanotechnologies. Section 8.3.3, paragraphs 24, 23, and 25.
137. Calster GV, Bowman DM. Regulatory Design for New Technologies: Spaghetti Junction or Bauhaus Principles for Regulating Innovative Cosmetic Products. 2009; XXV, 94:75-93
138. Stafford N. New nano rule for EU cosmetics, Advancing the Chemical Sciences, 2009, Royal society of Chemistry, Hamburg, Germany.
139. Burke K. Nanotech widespread in cosmetics, report finds, The Sydney Morning Herald, Nov. 24, 2009.
140. European Commission, Health and Consumer Protection Directorate-General, Scientific Committee on consumer Product, The SCCP notes of guidance for the testing of Cosmetic ingredients and their safety evaluation , 6th Revision, Adopted by the SCCP during the 10th plenary meeting of 19 December 2006.
141. U.S. Environmental Protection Agency Office Of Inspector General, EPA Needs to Manage Nanomaterial Risks More Effectively, Report No. 12-P-0162, December 29, 2011.
142. Perspectives on FDA's Regulation of Nanotechnology: Emerging Challenges and Potential Solutions, Institute of Food technologist, 2009; 8(4).
Published
01-07-2012
Statistics
Abstract Display: 1482 
PDF Downloads: 750
Dimension Badge
How to Cite
“LATEST TECHNOLOGY ADVANCES IN COSMACEUTICALS”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 4, no. 3, July 2012, pp. 168-82, https://doi.org/10.25004/IJPSDR.2012.040302.
Issue
Section
Review Article
Copyright (c) 2012 Nageen Arora, Shilpi Agarwal, R. S. R. Murthy
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
“LATEST TECHNOLOGY ADVANCES IN COSMACEUTICALS”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 4, no. 3, July 2012, pp. 168-82, https://doi.org/10.25004/IJPSDR.2012.040302.
